comparemela.com

Page 8 - Avxl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anavex Life Sciences (NASDAQ:AVXL) Trading Up 5 8%

Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) shares were up 5.8% during mid-day trading on Wednesday . The company traded as high as $8.25 and last traded at $8.22. Approximately 590,625 shares traded hands during trading, a decline of 47% from the average daily volume of 1,122,674 shares. The stock had previously closed at […]

StockNews com Initiates Coverage on Anavex Life Sciences (NASDAQ:AVXL)

Stock analysts at StockNews.com began coverage on shares of Anavex Life Sciences (NASDAQ:AVXL – Get Rating) in a research note issued to investors on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. A number of other research analysts also recently weighed in on the company. Jonestrading raised their price target on […]

Teacher Retirement System of Texas Acquires 13,841 Shares of Anavex Life Sciences Corp (NASDAQ:AVXL)

Teacher Retirement System of Texas grew its holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) by 119.9% in the third quarter, Holdings Channel reports. The firm owned 25,383 shares of the biotechnology company’s stock after buying an additional 13,841 shares during the quarter. Teacher Retirement System of Texas’ holdings in Anavex Life Sciences […]

Anavex Life Sciences Corp (NASDAQ:AVXL) Shares Purchased by Barclays PLC

Barclays PLC increased its position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) by 1,792.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 189,290 shares of the biotechnology company’s stock after acquiring an additional 179,290 shares during the quarter. […]

Anavex Life Sciences Corp (NASDAQ:AVXL) Given Average Recommendation of Buy by Analysts

Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Rating) has been given a consensus rating of “Buy” by the seven research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation and six have assigned a buy recommendation to the company. The average twelve-month price […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.